Upcoming Webinars

 

Understanding Wearables, Heart Data, and the OCORO Heart Study

Date: May 20, 2026

Time: 6:00pm EDT

 

Join us for an educational webinar about wearable devices, heart data, and what these tools may help us learn about living with a heart condition. We’ll talk about what devices are currently being used and what types of  data that they collect.

We’ll also share an overview of the OCORO Heart Study, a remote research study for people living with heart conditions. The goal of the study is to help researchers better understand how heart conditions change over time in real life. Participation is done from home, and the study is observational only, meaning there are no drugs, procedures, or clinic visits involved. We’ll explain what taking part may look like, who may be eligible, and how to learn more.

Presenter: Greg Kurio, MD, Cardiologist and Principal Investigator, OCORO Heart Study

AFTX-201: A next-generation, one-time genetic medicine for BAG3 DCM

Date: June 10, 2026

Time: 6:00pm EDT

 
Please join us for an educational webinar about AFTX-201, a next generation, investigational gene therapy that has been designed as a one-time treatment for patients with dilated cardiomyopathy due to mutations in the BAG3 gene. We’ll talk about the journey of Affinia Therapeutics and AFTX-201 to the first-in-human clinical trial.
 
We’ll also share an overview of the UPBEAT© trial, a multi-center, open-label, Phase 1b/Phase 2, dose-exploration, and dose-expansion trial of AFTX-201 for patients with dilated cardiomyopathy due to mutations in BAG3. The goal of the study is to help researchers better understand the safety and potential for efficacy of AFTX-201. We’ll explain what taking part may look like, who may be eligible, and how to learn more.
 
There will also be a Question-and-Answer section at the end of the webinar to answer any questions that you might have.
 
If you, a family member, or someone that you know has dilated cardiomyopathy due to mutations in the BAG3 gene you should attend. We also encourage all Health Care Providers that might have patients with mutations in the BAG3 gene to join this webinar.
 
Presenters:
Hideo Makimura, M.D., Ph.D.
Chief Medical Officer
Affinia Therapeutics
 
Arvind Bhimaraj, M.D.
Advanced Heart Failure Cardiologist and Physician Scientist
Principal Investigator, UPBEAT© trial
Houston Methodist Hospital